Skip to content

NAOV

NanoVibronix, Inc.

NASDAQ · Healthcare · Medical - Devices · US

$1.90
+1.06%
Ask drillr

Income statement

MetricTTM2024202320222021
Revenue
Total Revenue2.7M2.6M2.3M752.0K1.7M
Cost of Revenue1.9M1.1M746.0K585.0K925.0K
Gross Profit806.0K1.5M1.5M167.0K770.0K
Operating Expenses
R&D Expense2.1M909.0K185.0K283.0K293.0K
SG&A Expense8.2M4.2M4.8M4.9M6.2M
General & Admin Expense6.1M3.5M3.9M3.9M5.1M
Selling & Marketing Expense2.1M720.0K864.0K965.0K1.1M
Other Expenses
Total Operating Expenses10.3M5.1M5.0M5.2M6.5M
Cost and Expenses12.1M6.1M5.7M5.8M7.4M
Operating Income (EBIT)(9.4M)(3.6M)(3.4M)(5.0M)(5.7M)
Non-Operating
Interest Income(22.0K)31.0K
Interest Expense294.0K135.0K246.0K347.0K
Net Interest Income(316.0K)(104.0K)(246.0K)(347.0K)
Other Non-Op Income/Expense2.2M(104.0K)(246.0K)(401.0K)(8.6M)
Non-Operating Income (excl Interest)(2.5M)104.0K111.0K401.0K8.6M
EBT (Pre-Tax Income)(7.3M)(3.7M)(3.7M)(5.4M)(14.3M)
Income Tax Expense117.0K19.0K29.0K35.0K32.0K
Bottom Line
Net Income(3.6M)(3.7M)(3.7M)(5.4M)(14.3M)
Earnings from Cont. Ops(7.4M)(3.7M)(3.7M)(5.4M)(14.3M)
Earnings from Discont. Ops
Bottom Line Net Income(5.2M)(3.7M)(3.7M)(5.4M)(14.3M)
Per Share
Basic EPS($10.34)($13.73)($21.20)($38.40)($113.50)
Diluted EPS($10.34)($13.73)($21.20)($38.40)($113.50)
Revenue Per Share$5.54$9.48$13.04$5.30$13.47
Shares
Basic Shares Outstanding484566269848175010141967125814
Diluted Shares Outstanding484566269848175010141967125814
Profitability Metrics
EBITDA(6.3M)(3.7M)(3.5M)(5.4M)(14.2M)
D&A639.0K1.0K1.0K1.0K2.0K
EBIT(7.0M)(3.7M)(3.5M)(5.4M)(14.3M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Sep 1, 2025